60 likes | 72 Views
Rapid increase in the global disease burden and rise in the demand for blood- and plasma-derived products such as platelets, immunoglobulin, and plasma factors are augmenting the demand for immunohematology testing instruments and reagents. The number of patients with different hematological and other chronic diseases is also increasing rapidly across the world.
E N D
©2019 Transparency Market Research, All Rights Reserved Immunohematology Market Product - Analyzers (Automatic and Semi-automatic/Non- automatic), Reagents; Application - Blood Typing, Antibody Screening; End use - Hospitals, Academic and Research Institutes, Diagnostic and Reference Laboratories, Blood Banks - Forecast 2017 - 2025 ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 Market Dynamics Chapter 6 Immunohematology Market Analysis, by Product Chapter 7 Immunohematology Market Analysis, by Application Chapter 8 Immunohematology Market Analysis, by End-user Chapter 9 Immunohematology Market Analysis, by Region Chapter 10 North America Immunohematology Market Analysis Chapter 11 Europe Immunohematology Market Analysis Chapter 12 Asia Pacific Immunohematology Market Analysis Chapter 13 Latin America Immunohematology Market Analysis Chapter 14 Middle East & Africa Immunohematology Market Analysis Chapter 15 Company Profiles
©2019 Transparency Market Research, All Rights Reserved Immunohematology Market: Snapshot • Rapid increase in the global disease burden and rise in the demand for blood- and plasma-derived products such as platelets, immunoglobulin, and plasma factors are augmenting the demand for immunohematology testing instruments and reagents. • Awareness among the general public regarding the importance of blood compatibility and transfusion-related diseases is increasing due to the development of health care infrastructure, government campaigns, and increasing per capita income in developed as well as developing countries. • Technological improvements in devices and reagents available for immunohematology testing have enabled clinicians to provide proper emergency assistance to patients. • Major companies operating in the immunohematology market and profiled in the report are Bio-Rad Laboratories, Inc., Grifols S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc. ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved Reports Highlights • global immunohematology market was valued at US$ 1,462.1 Mn in 2016 and is projected to expand at a CAGR of 3.5% from 2017 to 2025 to reach value of US$ 1,991.8 Mn by 2025. • Advancements in the immunohematology technology have led to rapid development in the diagnostic approach toward in vitro study of the antigen–antibody interaction, facilitating improvement in the compatibility reaction between the donor’s blood and the recipient’s blood. • Increasing disposable income, rising health care awareness, and developing health care infrastructure have led to steady rise in the demand for better diagnosis and treatment measures in these countries. • The global immunohematology market has been segmented in terms of product, application, end-user, and geography. ©2019 Transparency Market Research, All Rights Reserved Request Sample
©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U